| Appearance and Shape (20°C) | Solid |
|---|---|
| CAS RN | 67219-55-0 |
| MDL number | MFCD00010114 |
| Molecular weight | 633.70 |
| Molecular Formula | C37H35N3O7 |
| Product code | ICTB3087 |
| PubChem Substance ID | 87559863 |
| Purity/Analytical Methods | >99.0%(HPLC) |
| Reaxys-RN | 601627 |
| SDBS (AIST Spectral DB) | 52136 |
| Situations to avoid | Light Sensitive,Hygroscopic |
| Store under inert gas | Store under inert gas |
| Appearance | White to Almost white powder to crystaline |
|---|
| Pictograms |
|
|---|---|
| Hazard statement | H351 : Suspected of causing cancer. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant P202 : Do not handle until all safety precautions have been read and understood P201 : Obtain special instructions before use P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection P308 + P313 : IF exposed or concerned: Get medical advice/ attention P405 : Store locked up. |
| Signal word | Warning |
Chemicals by Class 6-Membered Heterocyclic Compounds [Chemical Structural Class] Pyrimidines [Chemical Structural Class] Cytosines [Chemical Structural Class]
Chemistry Building Blocks Heterocyclic Building Blocks Non-Halogenated Heterocyclic Building Blocks Pyrimidines [Non-Halogenated Heterocyclic Building Blocks] Chemical Biology Nucleic Acid Chemistry Protected Nucleosides [Nucleic Acid Synthesis] Pharmaceutical Development and Drug Discovery Research Reagents Nucleic Acid Chemistry Protected Nucleosides [Nucleic Acid Synthesis]
Life Science Biochemicals and Reagents Nucleosides, Nucleotides, Oligonucleotides Nucleoside Analogs Nucleosides Pyrimidine Nucleoside Analogs Pyrimidine Nucleosides Pharmaceutical Development and Drug Discovery Research Nucleic Acid Chemistry Protected Nucleosides [Nucleic Acid Synthesis]